• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Nasdaq Rises 2.5%; ACADIA Pharmaceuticals Shares Plummet

    6/21/22 2:42:59 PM ET
    $ACAD
    $BHAT
    $BPT
    $CNVY
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Recreational Games/Products/Toys
    Consumer Discretionary
    Get the next $ACAD alert in real time by email

    U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining over 2.5% on Tuesday.

    The Dow traded up 2.09% to 30,445.81 while the NASDAQ rose 2.58% to 11,076.53. The S&P also rose, gaining, 2.44% to 3,764.68.

    Also check this: US Existing Home Sales And Other Macro Issues For Tuesday


    Leading and Lagging Sectors


    Energy shares jumped by 5.4% on Tuesday. Meanwhile, top gainers in the sector included BP Prudhoe Bay Royalty Trust (NYSE:BPT), up 18% and VAALCO Energy, Inc. (NYSE:EGY) up 15%.


    In trading on Tuesday, materials shares rose by just 1.5%.


    Top Headline


    Lennar Corporation (NYSE:LEN) reported better-than-expected results for its second quarter on Tuesday.

    Lennar posted adjusted earnings of $4.69 per share, beating analysts’ estimates of $3.98 per share. The company’s quarterly sales came in at $8.36 billion, versus expectations of $8.11 billion.

    The company said it sees Q3 deliveries of 17,000 to 18,500.

     

    Equities Trading UP


    Convey Health Solutions Holdings, Inc. (NYSE:CNVY) shares shot up 139% to $10.30 as the company agreed to be taken private by TPG Capital,.


    Shares of Valneva SE (NASDAQ:VALN) got a boost, shooting 89% to $25.90. Pfizer will invest €90.5 million ($95 million) for an 8.1% stake in Valneva, as the companies updated the terms of agreement for Lyme disease vaccine candidate VLA15.


    Lexaria Bioscience Corp. (NASDAQ:LEXX) shares were also up, gaining 18% to $2.74 as the company signed manufacturing and license agreements with Atlanta-based BevNology LLC.

     

    Equities Trading DOWN

    ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) shares tumbled 33% to $13.00. A panel of the FDA's outside experts voted 9-3 that Acadia Pharmaceuticals’ pimavanserin doesn't appear to be effective at treating patients with Alzheimer's-related psychosis.


    Shares of Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ:BHAT) were down 41% to $0.68. Blue Hat Interactive Entertainment Technology reported a proposed underwritten public offering of ordinary shares and pre-funded warrants to purchase ordinary shares.


    The ODP Corporation (NASDAQ:ODP) was down, falling 11% to $31.07. ODP completed realignment of operating business entities to better serve customers.


    Also check out: Kraft Heinz And 2 Other Stocks Insiders Are Selling


    Commodities

    In commodity news, oil traded up 0.7% to $110.33, while gold traded down 0.2% to $1,836.20.


    Silver traded up 0.7% to $21.73 on Tuesday while copper rose 0.4% to $4.0310.



    Euro zone


    European shares closed mostly higher today. The eurozone’s STOXX 600 gained 0.35%, London’s FTSE 100 rose 0.42% while Spain’s IBEX 35 Index fell 0.61%. The German DAX gained 0.20%, French CAC 40 climbed 0.75% and Italy’s FTSE MIB Index climbed 0.39%.

    The Euro Area recorded a current account gap of EUR 5.4 billion in April versus a year-ago surplus of EUR 32.3 billion.

     

    Economics


    The Chicago Fed National Activity Index fell to an eight-month low of +0.01 in May from +0.40 in the prior month.


    Existing home sales dropped by 3.4% to an annual rate of 5.41 million in May.


    Federal Reserve Bank of Richmond President Thomas Barkin will speak at 3:30 p.m. ET.

    Check out this: U.S. Markets Open Higher; Lennar Earnings Top Views

    Check out our premarket coverage here

    COVID-19 Update

    The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 88,054,080 cases with around 1,038,380 deaths. India confirmed a total of at least 43,320,840 cases and 524,890 deaths, while Brazil reported over 31,756,110 COVID-19 cases with 669,210 deaths. In total, there were at least 544,958,040 cases of COVID-19 worldwide with more than 6,342,090 deaths.

    Get the next $ACAD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACAD
    $BHAT
    $BPT
    $CNVY

    CompanyDatePrice TargetRatingAnalyst
    Lennar Corporation
    $LEN
    1/7/2026Mkt Outperform → Mkt Perform
    Citizens JMP
    Lennar Corporation
    $LEN
    1/6/2026$122.00Buy → Neutral
    UBS
    Lennar Corporation
    $LEN
    12/18/2025$95.00Sector Perform → Underperform
    RBC Capital Mkts
    Lennar Corporation
    $LEN
    12/18/2025$92.00In-line → Underperform
    Evercore ISI
    Lennar Corporation
    $LEN
    12/18/2025$95.00Neutral → Underperform
    BofA Securities
    Lennar Corporation
    $LEN
    12/8/2025$98.00Equal Weight → Underweight
    Barclays
    Lennar Corporation
    $LEN
    12/4/2025$115.00Neutral → Underweight
    Analyst
    Lennar Corporation
    $LEN
    12/2/2025$96.00Sell
    BTIG Research
    More analyst ratings

    $ACAD
    $BHAT
    $BPT
    $CNVY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    VAALCO Energy, Inc. Announces Agreement to Divest Non-Core Asset

    HOUSTON, Feb. 05, 2026 (GLOBE NEWSWIRE) -- VAALCO Energy, Inc. (NYSE:EGY, LSE: EGY)) ("Vaalco" or the "Company") today announced that it had entered into an agreement for the sale of all of its non-core producing properties in Canada to a third party for approximately $35.0 million Canadian Dollars (USD $25.6 million), subject to customary closing adjustments (the "Canadian Asset Sale"). The Canadian properties current working interest ("WI") production is approximately at 1,850 barrels of oil equivalent per day ("BOEPD"). The effective date of the Canadian Asset Sale is February 1, 2026, and it is expected to close within the next 30 days, subject to satisfaction of the customary closing

    2/5/26 2:00:00 AM ET
    $EGY
    Oil & Gas Production
    Energy

    Acadia Pharmaceuticals to Announce Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026

    Company to host conference call and webcast on Wednesday, February 25, 2026, at 4:30 p.m. Eastern Time Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) today announced that it will report fourth quarter and full year 2025 financial results on Wednesday, February 25, 2026, after the close of the U.S. financial markets. Acadia's management team will also host a conference call and webcast on February 25, 2026, at 4:30 p.m. Eastern Time. The conference call will be available on Acadia's website, acadia.com under the investors section and will be archived there until May 24, 2026. The conference call may also be accessed by registering for the call here. Once registered, participants will receive

    2/4/26 4:05:00 PM ET
    $ACAD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    "Trump Homes" Ignite a New Housing Trade

    DENVER, Feb. 04, 2026 (GLOBE NEWSWIRE) --  In a move that could reshape America's housing landscape, major builders are pitching "Trump Homes," a massive rent-to-own initiative aimed at tackling the affordability crisis with up to 1 million entry-level homes. Spearheaded by industry giants like Lennar (NYSE:LEN) and Taylor Morrison, the proposal envisions private investors funding the builds, with renters' payments accruing toward down payments after three years. This could unleash over $250 billion in housing development, blending private capital with White House-friendly policies amid sky-high home prices and interest rates. The plan, still in refinement and not yet under active White H

    2/4/26 9:35:49 AM ET
    $BLDR
    $LEN
    $RKT
    RETAIL: Building Materials
    Consumer Discretionary
    Homebuilding
    Finance: Consumer Services

    $ACAD
    $BHAT
    $BPT
    $CNVY
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for NUPLAZID issued to ACADIA PHARMS INC

    Submission status for ACADIA PHARMS INC's drug NUPLAZID (SUPPL-9) with active ingredient PIMAVANSERIN TARTRATE has changed to 'Approval' on 09/15/2023. Application Category: NDA, Application Number: 210793, Application Classification: Efficacy

    9/18/23 10:47:05 AM ET
    $ACAD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for NUPLAZID issued to ACADIA PHARMS INC

    Submission status for ACADIA PHARMS INC's drug NUPLAZID (SUPPL-12) with active ingredient PIMAVANSERIN TARTRATE has changed to 'Approval' on 09/15/2023. Application Category: NDA, Application Number: 207318, Application Classification: Efficacy

    9/18/23 10:40:05 AM ET
    $ACAD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for DAYBUE issued to ACADIA PHARMS INC

    Submission status for ACADIA PHARMS INC's drug DAYBUE (ORIG-1) with active ingredient TROFINETIDE has changed to 'Approval' on 03/10/2023. Application Category: NDA, Application Number: 217026, Application Classification: Type 1 - New Molecular Entity

    3/13/23 10:37:07 AM ET
    $ACAD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACAD
    $BHAT
    $BPT
    $CNVY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Bunka Christopher bought $25,241 worth of shares (27,500 units at $0.92) (SEC Form 4)

    4 - Lexaria Bioscience Corp. (0001348362) (Issuer)

    7/30/25 5:12:54 PM ET
    $LEXX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Mckechnie William Edward bought $4,532 worth of shares (5,000 units at $0.91), increasing direct ownership by 38% to 18,191 units (SEC Form 4)

    4 - Lexaria Bioscience Corp. (0001348362) (Issuer)

    7/30/25 12:37:08 PM ET
    $LEXX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    President & CSO Docherty John Martin bought $4,989 worth of shares (5,376 units at $0.93) (SEC Form 4)

    4 - Lexaria Bioscience Corp. (0001348362) (Issuer)

    7/30/25 11:34:10 AM ET
    $LEXX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACAD
    $BHAT
    $BPT
    $CNVY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, CHIEF LEGAL OFFICER, SEC Rhodes Jennifer J converted options into 12,944 shares and sold $162,491 worth of shares (6,950 units at $23.38), increasing direct ownership by 371% to 7,609 units (SEC Form 4)

    4 - ACADIA PHARMACEUTICALS INC (0001070494) (Issuer)

    2/10/26 6:00:04 PM ET
    $ACAD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Executive Chairman & CEO Miller Stuart A was granted 230,118 shares and covered exercise/tax liability with 25,913 shares, increasing direct ownership by 21% to 1,168,244 units (SEC Form 4)

    4 - LENNAR CORP /NEW/ (0000920760) (Issuer)

    1/22/26 6:33:21 PM ET
    $LEN
    Homebuilding
    Consumer Discretionary

    VP & Chief Financial Officer Bessette Diane J was granted 41,250 shares and covered exercise/tax liability with 6,871 shares, increasing direct ownership by 11% to 338,868 units (SEC Form 4)

    4 - LENNAR CORP /NEW/ (0000920760) (Issuer)

    1/22/26 6:20:52 PM ET
    $LEN
    Homebuilding
    Consumer Discretionary

    $ACAD
    $BHAT
    $BPT
    $CNVY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Lennar downgraded by Citizens JMP

    Citizens JMP downgraded Lennar from Mkt Outperform to Mkt Perform

    1/7/26 8:57:14 AM ET
    $LEN
    Homebuilding
    Consumer Discretionary

    Lennar downgraded by UBS with a new price target

    UBS downgraded Lennar from Buy to Neutral and set a new price target of $122.00

    1/6/26 8:46:59 AM ET
    $LEN
    Homebuilding
    Consumer Discretionary

    Lennar downgraded by RBC Capital Mkts with a new price target

    RBC Capital Mkts downgraded Lennar from Sector Perform to Underperform and set a new price target of $95.00

    12/18/25 9:01:04 AM ET
    $LEN
    Homebuilding
    Consumer Discretionary

    $ACAD
    $BHAT
    $BPT
    $CNVY
    SEC Filings

    View All

    VAALCO Energy Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - VAALCO ENERGY INC /DE/ (0000894627) (Filer)

    2/10/26 4:39:33 PM ET
    $EGY
    Oil & Gas Production
    Energy

    SEC Form F-1 filed by Blue Hat Interactive Entertainment Technology

    F-1 - Blue Hat Interactive Entertainment Technology (0001759136) (Filer)

    2/9/26 5:02:30 PM ET
    $BHAT
    Recreational Games/Products/Toys
    Consumer Discretionary

    Lexaria Bioscience Corp. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

    8-K - Lexaria Bioscience Corp. (0001348362) (Filer)

    2/6/26 4:30:40 PM ET
    $LEXX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACAD
    $BHAT
    $BPT
    $CNVY
    Leadership Updates

    Live Leadership Updates

    View All

    Lennar Announces the Retirement of Jonathan Jaffe, Co-CEO and President

    MIAMI, Nov. 14, 2025 /PRNewswire/ -- Lennar Corporation (NYSE:LEN), one of the nation's leading homebuilders, today announced that Lennar Co-Chief Executive Officer and President Jon Jaffe will retire effective December 31, 2025, following a distinguished 42-year career with the Company, and he will also step down from his role as a Director of the Board of the Company. After Mr. Jaffe's retirement, Stuart Miller will continue to serve as Executive Chairman and serve as Chief Executive Officer of Lennar, with no plans to replace Mr. Jaffe's role. Mr. Jaffe joined Lennar in 1983 as an assistant superintendent in Tampa, and through decades of hard work, unwavering commitment, and numerous val

    11/14/25 5:20:00 PM ET
    $LEN
    Homebuilding
    Consumer Discretionary

    Acadia Pharmaceuticals Appoints Konstantina Katcheves as Senior Vice President, Chief Business and Strategy Officer

    Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) today announced the appointment of Konstantina ("Tina") Katcheves as Senior Vice President, Chief Business and Strategy Officer. In this role, Tina will lead Acadia's business development and corporate strategy and serve as a member of the Company's Executive Leadership Team, reporting to Catherine Owen Adams, Chief Executive Officer of Acadia. "Tina brings a wealth of experience in global business development and strategic partnerships that will be instrumental as we continue to expand our pipeline and pursue high-impact growth opportunities," said Catherine Owen Adams, Chief Executive Officer of Acadia Pharmaceuticals. "Her leadership and deep i

    8/25/25 4:05:00 PM ET
    $ACAD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Title Resources Group Adds Accomplished Title Professional to Expand East Coast and Midwest Territories

    DALLAS, Aug. 7, 2025 /PRNewswire/ -- Title Resources Group (TRG), one of the nation's leading title insurance underwriters, has appointed Janell Downing as Agency Account Manager for Ohio, New Jersey and Pennsylvania. A seasoned title professional, Downing will drive business development efforts in these territories by forming and managing relationships with title insurance agents while supporting their growth initiatives. "Janell's extensive background on both the title agency and underwriter side made her the perfect fit for this role," said Kim Midgett, senior vice presiden

    8/7/25 10:45:00 AM ET
    $HOUS
    $LEN
    $OPEN
    Real Estate
    Finance
    Homebuilding
    Consumer Discretionary

    $ACAD
    $BHAT
    $BPT
    $CNVY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Lexaria Bioscience Corp.

    SC 13G/A - Lexaria Bioscience Corp. (0001348362) (Subject)

    11/14/24 4:11:11 PM ET
    $LEXX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by The ODP Corporation

    SC 13G/A - ODP Corp (0000800240) (Subject)

    11/14/24 4:05:16 PM ET
    $ODP
    Other Specialty Stores
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by ACADIA Pharmaceuticals Inc.

    SC 13G/A - ACADIA PHARMACEUTICALS INC (0001070494) (Subject)

    11/14/24 6:48:52 AM ET
    $ACAD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACAD
    $BHAT
    $BPT
    $CNVY
    Financials

    Live finance-specific insights

    View All

    Acadia Pharmaceuticals to Announce Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026

    Company to host conference call and webcast on Wednesday, February 25, 2026, at 4:30 p.m. Eastern Time Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) today announced that it will report fourth quarter and full year 2025 financial results on Wednesday, February 25, 2026, after the close of the U.S. financial markets. Acadia's management team will also host a conference call and webcast on February 25, 2026, at 4:30 p.m. Eastern Time. The conference call will be available on Acadia's website, acadia.com under the investors section and will be archived there until May 24, 2026. The conference call may also be accessed by registering for the call here. Once registered, participants will receive

    2/4/26 4:05:00 PM ET
    $ACAD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Lennar Corporation Declares Quarterly Dividends

    MIAMI, Jan. 21, 2026 /PRNewswire/ -- Lennar Corporation (NYSE:LEN), one of the nation's leading homebuilders, announced that its Board of Directors has declared a quarterly cash dividend of $0.50 per share for both Class A and Class B common stock payable on February 19, 2026 to holders of record at the close of business on February 4, 2026. About LennarLennar Corporation, founded in 1954, is one of the nation's leading builders of quality homes for all generations. Lennar builds affordable, move-up and active adult homes primarily under the Lennar brand name. Lennar's Financial Services segment provides mortgage financing, title and closing services primarily for buyers of Lennar's homes a

    1/21/26 4:30:00 PM ET
    $LEN
    Homebuilding
    Consumer Discretionary

    VAALCO Energy, Inc. Provides Positive Operational and Financial Update

    HOUSTON, Jan. 15, 2026 (GLOBE NEWSWIRE) -- VAALCO Energy, Inc. (NYSE:EGY, LSE: EGY)) ("Vaalco" or the "Company") today provided an operational and financial update including production and sales volumes for 2025, a successful drilling update in Gabon and Egypt, positive accounts receivables update and its increased cash at bank as of December 31, 2025. Highlights and Key Items: Recorded full year 2025 sales volumes of approximately 22,100 working interest ("WI") barrels of oil equivalent per day ("BOEPD"), at the top of its guidance range of 20,800 to 22,200 WI BOEPD; Produced approximately 21,150 WI BOEPD for full year 2025, at the midpoint of its full year guidance range; Increased cas

    1/15/26 2:00:00 AM ET
    $EGY
    Oil & Gas Production
    Energy